GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of three years of NHS threads, summarised so you do not have to read them — 46 comments in the full submission. View in context.
1.7k
c/glp1uk·submitted 2 years ago by u/rt_shift_reggie

three years of NHS threads, summarised so you do not have to read them

NHSbranch of 12 comments

three years of NHS threads, summarised so you do not have to read them. I have gone back and forth on this for months. GP said no in the spring, specialist said yes eighteen months later. Same person, same numbers. Concentrations can differ between products and between pharmacies. Switching mid-titration means…

Read the full submission and all 46 comments →

This branch

12 comments, started 2 years ago
u/niels_norgaard75 points·2 years ago

private and NHS pathways are not a ladder, they are separate routes

replysharereportpermalink
u/emil_marchand23 points·2 years ago

Correction: that threshold is your ICB’s, not a national one. They differ and they change by year.

replysharereportpermalink
u/rt_shift_reggieOP14 points·2 years ago·edited

Have you seen the current threshold published by your ICB?

replysharereportpermalink
u/arne_nyberg20 points·2 years ago

Same. My ICB threshold was different from the neighbouring one and nobody could tell me why.

replysharereportpermalink
u/marit_mensa6 points·2 years ago·edited

Same.

Adding the practical bit — ask what happens at discharge before you start, not after.

replysharereportpermalink
[removed]56 points·2 years ago

[removed by moderator]

replysharereportpermalink
u/emil_okwuosa19 points·2 years ago

Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.

replysharereportpermalink
u/lane_watchermod · logistics16 points·2 years ago

That is Scotland’s arrangement and the post is asking about England.

replysharereportpermalink
u/sorted_by_new9 points·2 years ago

Agreed. The ICB variation is the thing that makes national advice useless here.

replysharereportpermalink
u/rt_shift_reggieOP21 points·2 years ago

Is this a discharge back to the GP, or a discontinuation?

replysharereportpermalink
u/slow_logbook_notes-34 points·2 years ago

private prescription pricing moves monthly and the pharmacy is most of the spread

replysharereportpermalink
u/osman_eriksen1 point·2 years ago

The scheme cap in Ireland was the single most useful thing I learned in a year of reading this board.

replysharereportpermalink

← back to the whole thread

About c/glp1uk

UK-specific access: NHS tier-3 and specialist weight-management pathways, the two-year waiting-list reality, private prescription routes and their monthly cost, pharmacy stock, MHRA supply notices, and how the UK rules differ from the US conversation that dominates most of the internet.

43kmembers
95submissions
Jan 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1uk rules
  1. No naming online pharmacies that prescribe without a consultation.
  2. Price posts need the date — UK private pricing moves monthly.
  3. NHS pathway questions: say which nation. England, Scotland, Wales and NI differ.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.